Publicacións (26) Publicacións de Guillermo Pousada Fernández

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

  3. Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 3, pp. 595-607

  4. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2023

  1. Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic

    Viruses, Vol. 15, Núm. 2

  2. Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

    Viruses, Vol. 15, Núm. 4

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  3. Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain

    Frontiers in Public Health, Vol. 10

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

2020

  1. Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves’ disease patients

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 3, pp. 1538-1547

  2. Pulmonary arterial hypertension associated to systemic erythematosus lupus: molecular characterization of 3 cases

    Medicina Clinica, Vol. 151, Núm. 3, pp. 111-115

2017

  1. Cribado mutacional en genes relacionados con la hipertensión portopulmonar: análisis de 6 casos

    Medicina Clinica, Vol. 148, Núm. 7, pp. 310-313

  2. Functional analysis by minigene assay of putative splicing variants found in Bardet–Biedl syndrome patients

    Journal of Cellular and Molecular Medicine, Vol. 21, Núm. 10, pp. 2268-2275

  3. Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations

    Scientific Reports, Vol. 6

  2. Hipertensión arterial pulmonar asociada a infección por el virus de la inmunodeficiencia humana: análisis de 4 casos

    Medicina Clinica, Vol. 146, Núm. 8, pp. 350-353

  3. Methylation Analysis of the BMPR2 Gene Promoter Region in Patients With Pulmonary Arterial Hypertension

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 293-298

  4. Mutational and clinical analysis of the ENG gene in patients with pulmonary arterial hypertension

    BMC Genetics, Vol. 17, Núm. 1